StocksDBV TechnologiesDBV.PA

DBV.PA

DBV Technologies

3.57 -0.07 (-1.92%)
Prices By Xignite, in EUR Market Closed
Trade
S
3.57
B
3.60

Overview

Prev Close3.57
Day's Range 3.50 - 3.70
52 Week Range 2.16 - 9.86
Average Volume (3m)154.88K
1-Year Return-57.30%
Beta0.0876
Market Cap335.27M
P/E Ratio
Revenue0
EPS-1.1876
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.721/04/202204/07/202213/09/20222.503.003.504.004.505.005.50
Chart times in UTC
Industry Biotechnology
CEO Daniel Tassé
Employees 92

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: DBV Technologies's revenues decreased by NaN and amounted to 0.00. Net income increased by 40.88% to -82.75M. Net assets decreased by 48.02% to 87.30M and EPS increased from -2.59 to -1.51.
DBV.PA's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
N/A
Net Profit Margin
N/A
Operating Margin
N/A
Return On Investment
-99.32%
09/21
12/21
03/22
06/22
Total Revenue
0
0
0
0
Gross Profit
-921.34K
0
-4.83M
-4.99M
Operating Income
-21.8M
-19.82M
-19.32M
-23.82M
Net Income
-20.39M
-11.96M
-16.71M
-21.65M